C2C Wealth Management »

Regeneron Pharmaceuticals shares owned by C2C Wealth Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by C2C Wealth Management from 13F filings

Historical chart of C2C Wealth Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by C2C Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by C2C Wealth Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $976k 1.2k 813.37
2023-06-30 $1.0M 1.4k 727.04
2023-03-31 $1.3M 1.6k 820.85
2021-12-31 $253k 400 632.50

More positions owned by C2C Wealth Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Chevron Corporation (CVX)
Cohen & Steers infrastucture Fund (UTF)
Ishares Tr Russell 2000 Etf (IWM)
Select Sector Spdr Tr Technology (XLK)
International Business Machines (IBM)
Eaton Vance Tax Managed Diversified Eq. (ETY)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr S&p Mc 400gr Etf (IJK)
Enterprise Products Partners (EPD)

View all positions for C2C Wealth Management

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein

View all funds holding Regeneron Pharmaceuticals